Clinical trial participation after myocardial infarction in a national cardiovascular data registry.
暂无分享,去创建一个
J. D. de Lemos | M. Roe | P. Kohli | J. Udell | Tracy Y. Wang | S. Wiviott | Shuang Li
[1] Keith Humphreys,et al. Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010. , 2013, JAMA internal medicine.
[2] E. Antman,et al. Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being. , 2012, JAMA.
[3] S. Yusuf,et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. , 2010, The New England journal of medicine.
[4] W. Ahmad. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. , 2009 .
[5] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[6] K. Alexander,et al. Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score. , 2011, American heart journal.